Guardian Pharmacy Services Inc.

GRDN | NYSE

Price Alert Chart Builder DCF Calculator

$44.16

-$0.83 (-1.84%)

At close: Sep 21, 2026, 4:00 PM ET

$44.16

$0 (0.00%)

After-hours: Sep 21, 2026, 6:15 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.85B

Enterprise Value $2.71B

Beta 0.10

Average Volume 402.12K

Shares Outstanding (Diluted) 63.84M

Shares Change YoY 1%

Institutional Ownership 44.72%

Exchange NYSE

ISIN US40145W1018

Price Performance

Price Change 1M 16.4%

Price Change 3M 12.7%

Price Change 6M 21.0%

Price Change YTD 49.5%

Price Change 1Y 74.2%

Price Change 3Y 148.8%

Price Change 5Y 148.8%

1M CAGR (ann.) 14.0%

1Y CAGR (ann.) 65.6%

5Y CAGR (ann.) N/A

All-Time CAGR 68.7%

Valuation

PE Ratio 42.87

Forward PE 31.26

PEG Ratio 0.15

Forward PEG 4.41

PS Ratio 1.91

Forward PS 1.80

PB Ratio 10.85

P/FCF Ratio 34.59

P/Adj. FCF Ratio 40.68

P/OCF Ratio 28.31

EV/Sales 1.85

EV/EBIT 28.14

EV/EBITDA 23.81

EV/FCF 33.58

Earnings Yield 2.3%

FCF Yield 2.9%

Adj. FCF Yield 2.5%

Financial Health

Net Cash $82.43M

Total Debt $7.38M

Cash & Short-Term Investments $89.81M

Total Assets $443.58M

Current Ratio 1.65

Quick Ratio 1.33

Debt / Equity Ratio 0.14

Debt / EBITDA 0.06

Debt / FCF 0.09

OCF / Debt 14.23

Interest Coverage 145.39

Altman Z-Score 13.80

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 21.6%

Operating Profit Margin 6.3%

EBITDA Margin 7.8%

Net Profit Margin 4.5%

FCF Margin 5.5%

Adj. FCF Margin 4.7%

SBC / Revenue 0.7%

SBC Impact (per share) -15.0%

Returns

Return on Assets 14.9%

Return on Equity 30.8%

Return on Invested Capital 21.4%

Return on Capital Employed 31.7%

Return on Tangible Assets 19.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 14.4%

Revenue CAGR 5Y 21.6%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 10.7%

EPS CAGR 5Y 56.4%

EPS CAGR 10Y N/A

FCF CAGR 3Y 21.2%

FCF CAGR 5Y 32.6%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $9.71

Graham Upside -78.0%

Lynch Fair Value $25.75

Lynch Upside -41.7%

Price Target $48

Price Target Upside 8.7%

Cash Flow

Operating Cash Flow $104.92M

Free Cash Flow $80.83M

Adj. Free Cash Flow $68.74M

FCF Per Share $1.26

OCF Per Share $1.56

OCF/S Ratio 6.8%

Income Statement

Revenue $1.46B

Gross Profit $316.58M

Operating Income $91.74M

EBITDA $114M

Net Income $65.91M

EPS (Diluted) $1.03

Revenue / Employee $406.5K

Profit / Employee $18.31K

Employees 3,600